Krish Ramadurai is a Partner at Harmonix Fund, leading the firm's technical due diligence, investment sourcing, and portfolio operational support across their healthcare, life sciences, and deep technology practices. He is a multi-published author, advisor, lecturer, and former researcher at Harvard & MIT. While at Harvard, he worked with Nobel Laureate Economist Michael Kremer on the United States Agency for International Development's Innovation Ventures Fund and authored three books on medicine and applied engineering.
He serves as a venture advisor for Nucleate and is a board observer for Sorcero and xCures. He has been nominated for multiple industry awards including Forbes 30 Under 30 in venture capital and the NVCA Rising Star Award. He has advanced degrees in Biology, Nanotechnology & Nanomedicine, and Business Administration from Harvard University, Oxford University, and Washington University in St. Louis, respectively, and a bachelor's degree in Integrative Biology and Economics with a Chemistry minor from the University of Illinois at Urbana-Champaign.